Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
BMC Infect Dis
; 21(1): 411, 2021 May 04.
Article
in En
| MEDLINE
| ID: mdl-33947344
Full text:
1
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pneumonia, Viral
/
Ivermectin
/
COVID-19 Drug Treatment
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2021
Type:
Article